MEI Pharma, Inc.
MEIPNASDAQHealthcare
$3.07
+$0.29(+10.43%)
Market Cap$20452012
P/E Ratio—
52W High$9
52W Low$1.46
MEI Pharma, Inc. (MEIP) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MEIP · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.02B) | $0.02B | ($0.03B) | ($0.05B) | ($0.05B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | ($0.00B) | $0.00B | $0.00B | $0.01B | $0.01B |
| Change in Working Capital | ($0.00B) | ($0.08B) | ($0.02B) | $0.02B | $0.03B |
| Net Cash from Operations | ($0.02B) | ($0.05B) | ($0.05B) | ($0.05B) | ($0.03B) |
| Investing Activities | |||||
| Capital Expenditure | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | ($0.06B) | ($0.10B) | ($0.27B) | ($0.42B) |
| Sales of Investments | $0.03B | $0.11B | $0.16B | $0.28B | $0.45B |
| Net Cash from Investing | $0.04B | $0.05B | $0.05B | $0.01B | $0.02B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Dividends Paid | $0.00B | ($0.01B) | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.00B | ($0.01B) | ($0.00B) | $0.05B | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.02B) | ($0.05B) | ($0.05B) | ($0.05B) | ($0.03B) |
| FCF Margin %(computed) | — | -77.31% | -107.59% | -120.95% | -127.95% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more MEI Pharma, Inc. data
About MEI Pharma, Inc. (MEIP) Cash Flow Statement
MEI Pharma, Inc. generated operating cash flow of ($0.02B) and free cash flow of ($0.02B) for 2025 — a FCF margin of —. Capital expenditure was $0.00B.
Frequently asked questions
MEIP · 4 questionsMEI Pharma, Inc. generated free cash flow of ($0.02B) for 2025, up 58.7% year-over-year.
MEIP free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10